Olivia Newton-john Cancer Research Institute

This study tests whether combining two immunotherapy drugs, ipilimumab and nivolumab, can shrink or control rare cancers that have not responded to other treatments. The trial includes 240 adults with advanced biliary tract, neuroendocrine, gynecologic, or MSI-H solid tumors. Res…